Monitoring of anti-Xa activity and factors related to bleeding events: A study in Japanese patients with nonvalvular atrial fibrillation receiving rivaroxaban - Sakaguchi, T; Osanai, H; Murase, Y (J Cardiol, 2017)
, et al.